Literature DB >> 9222053

Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.

C Onody1, P Matsiota-Bernard, C Nauciel.   

Abstract

Ninety-eight consecutive clinical isolates of Legionella pneumophila were tested for erythromycin, rifampicin and ciprofloxacin susceptibility. MICs, determined by agar dilution testing, were in the range 0.06-1 mg/L of erythromycin, 0.007-0.015 mg/L of rifampicin and 0.015-0.03 mg/L of ciprofloxacin. No resistance against the antibiotics tested was detected. It is thus likely that therapeutic failures in legionnaires' disease are not related to the emergence of resistance against commonly used antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222053     DOI: 10.1093/jac/39.6.815

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Legionella.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

2.  Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.

Authors:  Ghislaine Descours; Christophe Ginevra; Nathalie Jacotin; Françoise Forey; Joëlle Chastang; Elisabeth Kay; Jerome Etienne; Gérard Lina; Patricia Doublet; Sophie Jarraud
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

3.  Identification of the aspartate-beta-semialdehyde dehydrogenase gene of Legionella pneumophila and characterization of a null mutant.

Authors:  O S Harb; Y Abu Kwaik
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.

Authors:  Julia Mallegol; Prabhavathi Fernandes; Roberto G Melano; Cyril Guyard
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

5.  Severe Legionnaires' Disease Complicated by Rhabdomyolysis and Clinically Resistant to Moxifloxacin in a Splenectomised Patient: Too Much of a Coincidence?

Authors:  Theocharis Koufakis; Ioannis Gabranis; Marianneta Chatzopoulou; Anastasios Margaritis; Maria Tsiakalou
Journal:  Case Rep Infect Dis       Date:  2015-11-22

6.  Emergence of Microbial Resistance During Hospitalization.

Authors:  Salvatore Bozzaro
Journal:  EBioMedicine       Date:  2015-08-06       Impact factor: 8.143

7.  KKL-35 Exhibits Potent Antibiotic Activity against Legionella Species Independently of trans-Translation Inhibition.

Authors:  Romain Brunel; Ghislaine Descours; Isabelle Durieux; Patricia Doublet; Sophie Jarraud; Xavier Charpentier
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.